How deadly is Breast cancer?

Fuula kana dhaggeeffadhu

Dhukkubni kaansarii busaa hammam nama ajjeesa?

Kaansariin busaa dhukkuba cimaa fi duʼuu dandaʼu dha.

Addunyaa irratti dubartoota gidduutti kaansarii baay'ee barame yoo ta'u, dubartoota keessatti sababa du'a kaansarii isa lammaffaa dha.

Akka American Cancer Society jedhutti, bara 20220, dubartoota Yunaayitid Isteetis keessatti dhukkubni kaansarii busaa haaraa 276,480 ta'e kan argame yoo ta'u, dubartoonni 42,170 ta'an ammoo kaansarii busaa irraa du'aniiru.

Haa ta'u malee, lakkoofsi namoota kaansarii saanduqaatiin du'an bara 1989 irraa kaasee hir'achaa kan jiru yoo ta'u, lakkoofsi namoota kaansarii saanduqaatiin du'an bara 1989 irraa hanga 2017tti %40 hir'ateera, kun immoo fooyya'iinsa qorannoo fi wal'aansa jalqabaa irraa kan ka'edha.

Balaan kaansarii busaa irraa du'uu, umrii, sadarkaa dhukkubichi itti argame fi gosa kaansarii busaa irratti hundaa'uun garaagarummaa qaba.

Yommuu dhukkubni kun dursamee hubatamuufi wal'aansa argachuu danda'u, carraan lubbuun ooluu baay'ee fooyya'a.

Ilaalchawwan

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

van Schoor G, Moss SM, Otten JD, Donders R, Paap E, den Heeten GJ, Holland R, Broeders MJ, Verbeek AL: Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer. 2011, 104 (6): 910-4.

DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL: Breast cancer statistics, 2019. CA Cancer J Clin. 2019, 69 (6): 438-451.

Icaza G, Núñez L, Bugueño H: [Epidemiological analysis of breast cancer mortality in women in Chile]. Rev Med Chil. 2017, 145 (1): 106-114.

Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, Kopans DB, Eby PR, Sickles EA: Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging. J Am Coll Radiol. 2017, 14 (9): 1137-1143.

Deaths from breast cancer--United States, 1991. MMWR Morb Mortal Wkly Rep. 1994, 43 (15): 273, 279-81.

Kuroishi T, Hirose K, Suzuki T, Tominaga S: Effectiveness of mass screening for breast cancer in Japan. Breast Cancer. 2000, 7 (1): 1-8.

Ejjennoo: fayyaa

Weebsaayitiin kun kaayyoo barnootaa fi odeeffannoo qofaaf kan qophaa'e yoo ta'u, gorsa fayyaa ykn tajaajila ogummaa kennuu miti.

Odeeffannoon kenname kun rakkoo fayyaa ykn dhukkuba tokko adda baasuuf ykn wal'aanuuf itti fayyadamuu hin qabu, namoonni gorsa fayyaa dhuunfaa barbaadanis ogeessa fayyaa hayyama qabu wajjin mari'achuu qabu.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numerical content. For example, the number of people diagnosed with a specific disease.

Yeroo hunda waa'ee dhukkuba tokkoo gorsa ogeessa fayyaa ykn ogeessa fayyaa ga'eessa ta'e biraa gaafadhu. Gorsa fayyaa ogeessaa hin tuffatin ykn waan weebsaayitii kana irratti dubbisteef isa barbaaduu hin daangeffatin. Yoo rakkoo fayyaa qabaachuu dandeessan yoo ta'e, hatattamaan 911 bilbilaa ykn gara kutaa ariifachiisaa dhihoo deemaa. Weebsaayitii kana ykn itti fayyadama isaatiin hariiroon ogeessa fayyaa fi dhukkubsataa hin uumamu. BioMedLib ykn hojjettoonni isaa, ykn namni weebsaayitii kana irratti gumaache kamiyyuu, odeeffannoo asitti kenname ykn itti fayyadama isaa ilaalchisee ibsa ykn yaada hin kennine hin kennine.

Ejjennoo: Mirga bu'uuraa

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) abbootii seeraa meeshaaleen intarneetii irratti mul'atan mirga isaanii seera abbaa seerummaa Yunaayitid Isteetis jalatti cabsu jedhanii amanuuf furmaata ni kenna.

Qabiyyeen ykn meeshaan Weebsaayitii keenya ykn tajaajila keenya waliin walqabatee qophaa'e kamiyyuu mirga abbaa seerummaa keessan kan cabsu akka ta'e amanuu yoo barbaadde, ati (yommuu ta'u bakka bu'aa keessan) qabiyyeen ykn meeshaan kun akka kaafamu ykn akka dhorkamu nutti himachuu ni danda'a.

Beeksisni barreeffamaan ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa

DMCA'n beeksiinsi keessan waa'ee cabsaa seeraa kan himatamu odeeffannoo armaan gadii akka dabalatu gaafata: (1) ibsa hojii seeraa kan cabsaa seeraa kan himatamu ta'e; (2) ibsa qabiyyee cabsaa seeraa kan himatamu fi odeeffannoo qabiyyee isaa akka argannu nu dandeessisu ga'aa ta'e; (3) odeeffannoo wal qunnamtii keessan, kan akka teessoo keessan, lakkoofsa bilbilaa fi teessoo iimeelii keessan; (4) ibsi keessan qabiyyee akkaataa komatamanitti akka hin hayyamamne amantaa gaarii akka qabdan ibsa;

(5) beeksifannaa keessatti odeeffannoon sirrii akka ta'e fi mirgi abbaa qabeenyaa akka cabse kan himatamu akka ta'e labsii ati mallatteessite;

fi (6) mallattoo qaamaa ykn elektirooniksii abbaa seeraa ykn nama bakka bu'aa abbaa seeraa ta'uun akka hojjetu hayyamame.

Odeeffannoowwan armaan olitti tarreeffaman hunda kan hin dabalne yoo ta'e, dhimmi komii keessan akka hin mari'atamne gochuu danda'a.

Walitti dhufeenyi

Gaaffii / yaada kamirrayyuu qabdan nutti ergi.

How deadly is breast cancer?

Breast cancer is a serious and potentially deadly disease.

It is the most common cancer among women worldwide and the second leading cause of cancer death in women.

According to the American Cancer Society, in 20220, an estimated 276,480 new cases of invasive breast cancer were diagnosed in women in the United States, and about 42,170 women in the U.S. died from breast cancer.

However, the death rate from breast cancer has been declining since 1989, with a 40% decrease in the breast cancer death rate from 1989 to 2017, largely due to improvements in early detection and treatment.

The risk of dying from breast cancer varies depending on factors such as age, stage at diagnosis, and the type of breast cancer.

Early detection and treatment can significantly improve the chances of survival.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.